Joseph G. Pressey · Physician and nurse beliefs of phase 1 trials in pediatric oncology
Follow
Article1 min read·Published Jan 2014Older

Physician and nurse beliefs of phase 1 trials in pediatric oncology

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Jan 2014 · 1 min read

In brief

In brief

This survey study compares physician and nurse perceptions of phase 1 pediatric oncology trials, revealing knowledge gaps between the two groups regarding trial goals and outcomes. While both professions hold positive views about early-phase trials, nurses require additional education to better support patient enrollment and trial monitoring.

Written by the GCMD Library team from the article.

Joseph G. Pressey

Background: In order to improve the survival of children with cancer, novel therapies must be identified. Promising agents are tested in phase 1 trials in order to identify appropriate dosing and describe toxicity in children. The identification and referral of candidate patients for phase 1 trials rely heavily on medical providers who must balance their own perceptions of phase 1 trials with the desires and willingness of the patient and his/her family. Objective: The goal of the present study was to evaluate and compare physician and nurse perceptions regarding the beliefs, expectations, and perceived benefits of phase 1 clinical trials. Methods: A survey consisting of 21 questions was sent to 419 physicians and nurses practicing pediatric oncology at 30 different institutions. With the exception of 10 demographic questions, items were either rank ordered or rated on 5-point Likert scales. Results: Ninety-four physicians and 122 nurses completed the online survey. Physicians and nurses differed in their knowledge of the goals and medical effects of phase 1 clinical trials. Conclusions: Physicians and nurses hold positive beliefs regarding phase 1 clinical trials and support their role in the treatment of children with cancer. Education is necessary to increase nurses' knowledge of the goals and outcomes. Implications For Practice: These findings suggest that continued education of nurses as well as physicians about the goals, execution, and monitoring of phase 1 therapy wou

Statements in this article

  1. Promising agents are tested in phase 1 trials in order to identify appropriate dosing and describe toxicity in children.

    EstablishedBackground
  2. The identification and referral of candidate patients for phase 1 trials rely heavily on medical providers who must balance their own perceptions of phase 1 trials with the desires and willingness of the patient and his/her family.

    EstablishedBackground
  3. A survey consisting of 21 questions was sent to 419 physicians and nurses practicing pediatric oncology at 30 different institutions.

    ResearchMethods
  4. Ninety-four physicians and 122 nurses completed the online survey.

    ResearchResults
  5. Physicians and nurses differed in their knowledge of the goals and medical effects of phase 1 clinical trials.

    ResearchResults
  6. Physicians and nurses hold positive beliefs regarding phase 1 clinical trials and support their role in the treatment of children with cancer.

    ResearchConclusions
  7. Education is necessary to increase nurses' knowledge of the goals and outcomes of phase 1 clinical trials.

    RecommendationConclusions
  8. Continued education of nurses as well as physicians about the goals, execution, and monitoring of phase 1 therapy is needed.

    RecommendationImplications For Practice

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.